Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04443894
Other study ID # BreastPecs
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 20, 2020
Est. completion date December 31, 2023

Study information

Verified date June 2020
Source Attikon Hospital
Contact Eleftheria Soulioti, MD,PhD
Phone 00306946745366
Email eleftheriasoulioti@ymail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Post mastectomy pain management is of crucial importance for patients' rehabilitation and quality of life. PECS block is used for acute and chronic post mastectomy pain management. Surgical infiltration is also used in this field. Patients in our study are divided in two groups receiving PECS block or surgical infiltrationbefore incision. Multimodal analgesia is indispensable according to recent guidelines for enhanced postoperative recovery. Pain scores will be assessed during the first 24h postoperatively and at 3 months after surgery.


Description:

Patients are randomly assigned to 2 groups, PECS block or surgical infiltration group. Patients assigned to PECS group will receive 30cc of ropivacaine 0,375% where 10cc will be injected between pectoralis major and pectoralis minor and 20cc between pectoralis minor and serratus anterior muscle under ultrasound guidance. Patients assigned to surgical infiltration group will receive 30cc of ropivacaine 0,375% injected by the surgeon. Local aneshetic is administered in both groups after the induction of general anesthesia and before incision. Pain will be assessed at 1, 12, 24h after surgery and at three months after surgery communicating by telephone. Post operative analgesia includes paracetamol 1gr, parecoxib 40 mg (as required) and tramadol as rescue analgesia (1 mg/kg iv up to 3 times daily). Chronic pain will be assessed after 3 months as for prevalence and neuropathic characteristics.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- over 18 years of age

- ASA physical status I-III

- elective partial mastectomy

Exclusion Criteria:

- refusal of patient participation or inability to participate to the study

- known allergic reaction to drugs included in the study design

- contraindiations of performance of peripheral regional anesthesia

- diabetes melitus or known neurological disorder

- chronic pain disorders under therapy with opioids or other analgesic drugs for chronic pain

- all male patients

- all patients not speaking the Greek language

Study Design


Related Conditions & MeSH terms

  • Chronic Pain
  • Immediate and Chronic Pain After Mastectomy Managed With PECS Block or Local Infiltration

Intervention

Other:
PECS block
PECS block is performed at the side of surgery (II) before incision with ropivacaine 0,375%.(30 ml). General anesthesia is induced and maintained with midazolam, fentanyl, propofol and rocuronium. Pain is assessed postoperatively according to protocol (24 hours and after 3 months).
local infiltration
local infiltration of the surgical wound before incision with pwith ropivacaine 0,375%.(30 ml). General anesthesia is induced and maintained with midazolam, fentanyl, propofol and rocuronium. Pain is assessed postoperatively according to protocol (24 hours and after 3 months).

Locations

Country Name City State
Greece 2nd Department of Anesthesiology, Attikon Hospital, 1 Rimini str. Athens

Sponsors (1)

Lead Sponsor Collaborator
Attikon Hospital

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary intensity of acute postoperative pain intensity of acute postoperative pain, numeric rating scale 0-10 24 hours
Secondary intensity of chronic pain intensity of chronic pain with numeric rating scale 0-10 3 months
Secondary Prevalence of chronic neuropathic pain Prevalence of chronic pain at the site of surgery, measured with the LANSS questionnaire 3 months
Secondary Prevalence of chronic neuropathic pain Prevalence of chronic pain at the site of surgery, measured with YES./NO 3 months